Hanmi Pharm (128940.KS) Earnings Analysis
Hanmi Pharm (128940.KS) has no confirmed upcoming earnings date. It has beaten estimates in 0/3 recent quarters (0%). Trailing P/E 25.92.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 128940.KS next report earnings?
No confirmed upcoming earnings date is currently scheduled for 128940.KS. This page updates as the calendar is published.
128940.KS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-30 | 3,587.5 KRW | n/a | n/a | n/a |
| 2026-02-05 | 5,200.32 KRW | n/a | n/a | n/a |
| 2025-07-25 | 2,882.58 KRW | n/a | n/a | n/a |
| 2025-04-28 | 3,360 KRW | 4,276.45 KRW | -21.4% | Miss |
| 2025-01-31 | -390.73289 KRW | 2,006.32 KRW | -119.5% | Miss |
| 2024-10-31 | 2,445 KRW | 3,039.76 KRW | -19.6% | Miss |
Beat rate: 0/3 (0%) over reported quarters with consensus data.
128940.KS valuation and analyst view
| Trailing P/E | 25.92 |
|---|---|
| Trailing EPS | 11,986.58 KRW |
| Price / book | 4.30 |
| Dividend yield | 0.58% |
| Market cap | 4679.00B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Hanmi Pharm (128940.KS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 128940.KS. This page updates as the calendar is published.
Did 128940.KS beat earnings last quarter?
Consensus estimate data was not available for 128940.KS's 2026-04-30 report.
What is 128940.KS's earnings track record?
Over the last 3 reported quarters with consensus data, 128940.KS beat estimates 0 times (0%).
What is 128940.KS's current P/E ratio and EPS?
128940.KS trades at a trailing P/E of 25.92 on trailing EPS of 11986.582371750314 KRW.
What do analysts rate 128940.KS?
128940.KS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.